ProMIS Neurosciences Correlations

PMN Stock  USD 11.24  0.36  3.31%   
Low or negative correlation with other holdings can meaningfully reduce portfolio drawdowns during market stress. The current 90-days correlation between ProMIS Neurosciences and Edesa Biotech is 0.03 (i.e., Very good diversification).

Correlation With Market: ProMIS Neurosciences

Strong inverse diversification
ProMIS Neurosciences currently posts a -0.28 correlation with Dow Jones, indicating a Strong inverse diversification relationship for the active sample. This chart measures the degree of risk overlap between ProMIS Neurosciences and Dow Jones.
  
ProMIS Neurosciences has a market cap of 97.57 M, an operating margin of -1223.97% for the last reported period, current ratio of 5.42. Historical return correlation between positions is a key input for construction decisions. Broader economic conditions can influence ProMIS Neurosciences's company valuation - related indicators include signals in board of governors.
Additional detail on trading ProMIS Stock is available in our How to Trade ProMIS Stock guide.

Moving Against ProMIS Stock

  0.5WINT Windtree TherapeuticsPairCorr
  0.47DRMA Dermata TherapeuticsPairCorr
  0.34VANI Vivani MedicalPairCorr
  0.33EBS Emergent BiosolutionsPairCorr
  0.62UPC Universe PharmaceuticalsPairCorr
  0.56EU6 PDS Biotechnology CorpPairCorr
  0.54XRTX XORTX Therapeutics TrendingPairCorr
  0.54LIXT Lixte BiotechnologyPairCorr
  0.48INSM Insmed Inc Earnings Call This WeekPairCorr
  0.41X90 PROBIOTIX HEALTHPairCorr
  0.39KYTX Kyverna TherapeuticsPairCorr
  0.37GOSS Gossamer BioPairCorr
  0.36ACW Actinogen MedicalPairCorr

Related Correlations Analysis


Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

BRTXERNA
BRTXGOVX
GOVXERNA
ANLMPLT
GOVXLPCN
BRTXOSRH
  

High negative correlations

LPCNMPLT
ANLLPCN
GOVXEDSA
EDSALPCN
THAROSRH
BRTXEDSA

Risk-Adjusted Indicators

Return momentum in ProMIS Stock is more useful when tested against peer-relative fundamentals and risk. Without risk-adjusted context, short-term returns may appear stronger than the volatility required to achieve them would suggest. These indicators are quantitative in nature and measure volatility and risk-adjusted expected returns across different positions.

ProMIS Neurosciences Corporate Management

Johanne KaplanChief Development OfficerProfile
David WishartChief Physics OfficerProfile
Larry MDChief Medical OfficerProfile
Dennis ChenHead of Manufacturing & Senior ConsultantProfile